Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma

Graphical abstract

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2016-08, Vol.65 (2), p.289-295
Main Authors: Abou-Alfa, Ghassan K, Puig, Oscar, Daniele, Bruno, Kudo, Masatoshi, Merle, Philippe, Park, Joong-Won, Ross, Paul, Peron, Jean-Marie, Ebert, Oliver, Chan, Stephen, Poon, Tung Ping, Colombo, Massimo, Okusaka, Takuji, Ryoo, Baek-Yeol, Minguez, Beatriz, Tanaka, Takayoshi, Ohtomo, Toshihiko, Ukrainskyj, Stacey, Boisserie, Frederic, Rutman, Olga, Chen, Ya-Chi, Xu, Chao, Shochat, Eliezer, Jukofsky, Lori, Reis, Bernhard, Chen, Gong, Di Laurenzio, Laura, Lee, Ray, Yen, Chia-Jui
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized
Carcinoma, Hepatocellular
CD16
Codrituzumab
Disease-Free Survival
Double-Blind Method
Female
Gastroenterology and Hepatology
Glypican-3
Glypicans
Hepatocellular carcinoma
Humans
Liver Neoplasms
Male
Middle Aged
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Graphical abstract
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2016.04.004